Missing/wrong data?
Log in to edit
Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study.
scientific article published on 21 March 2018
Author/s
author: Karen L. Reckamp, Rachel E Sanborn, George R Blumenschein, Christine M. Lovly
Work details
Publication date
March 21, 2018
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.